The Beijing Action Plan for Accelerating the Innovation and Development of "Artificial Intelligence + Medical Health" (2025-2027) was officially issued. It mentioned that relying on innovation entities such as national laboratories and new research and development institutions, research on basic theories and algorithms of artificial intelligence applicable to the field of life sciences, and use artificial intelligence technology to explore new methods and tools to reveal the essential laws of life and pathogenic mechanisms, break through technologies such as artificial intelligence virtual cells, medical digital twins, and DNA storage, and accelerate innovation in basic theories and cutting-edge technologies in life sciences. Explore the application research of cutting-edge technologies such as cognitive intelligence, brain-like intelligence, and super intelligence in the field of medicine and health. Support innovation entities to jointly develop independent and controllable multi-scale biomedical basic models such as molecules, cells, organs/systems, and achieve deep representation learning, cross-modal correlation analysis, and generative prediction of high-dimensional life science data by simulating molecular interactions, cell pathways, and system regulation, so as to improve the efficiency and success rate of target discovery and clinical trials.